PepGen Inc. (PEPG) stock
PEPGNasdaqPharmaceutical PreparationsFiscal year ends December 31
$3.83−0.05 (-1.29%)
Close on Nov 18, 2026Market cap $265.26MP/E –Yield –
PepGen shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
PepGen's shares outstanding was 69M at Jun 30, 2026. For fiscal 2025 it was 42M, up 33.7% from the year before. The highest annual figure on record is 42M in fiscal 2025.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 42M | +33.7% |
| FY2024 | Dec 31, 2024 | 32M | +32.7% |
| FY2023 | Dec 31, 2023 | 24M | +52.2% |
| FY2022 | Dec 31, 2022 | 16M | +1635.6% |
| FY2021 | Dec 31, 2021 | 1M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 69M | +111.3% |
| Q1 FY2026 | Mar 31, 2026 | 69M | +111.5% |
| Q4 FY2025 | Dec 31, 2025 | 69M | +111.8% |
| Q3 FY2025 | Sep 30, 2025 | 34M | +5.5% |
| Q2 FY2025 | Jun 30, 2025 | 33M | +0.9% |
| Q1 FY2025 | Mar 31, 2025 | 33M | +14.0% |
| Q4 FY2024 | Dec 31, 2024 | 33M | +36.9% |
| Q3 FY2024 | Sep 30, 2024 | 33M | +37.0% |
| Q2 FY2024 | Jun 30, 2024 | 32M | +36.5% |
| Q1 FY2024 | Mar 31, 2024 | 29M | +20.6% |
| Q4 FY2023 | Dec 31, 2023 | 24M | +0.5% |
| Q3 FY2023 | Sep 30, 2023 | 24M | +1.0% |
| Q2 FY2023 | Jun 30, 2023 | 24M | +68.8% |
| Q1 FY2023 | Mar 31, 2023 | 24M | +2366.0% |
| Q4 FY2022 | Dec 31, 2022 | 24M | +2469.2% |
| Q3 FY2022 | Sep 30, 2022 | 24M | +2535.4% |
| Q2 FY2022 | Jun 30, 2022 | 14M | +1476.0% |
| Q1 FY2022 | Mar 31, 2022 | 1M | +7.8% |
| Q4 FY2021 | Dec 31, 2021 | 1M | – |
| Q3 FY2021 | Sep 30, 2021 | 1M | – |
| Q2 FY2021 | Jun 30, 2021 | 1M | – |
| Q1 FY2021 | Mar 31, 2021 | 1M | – |
See a number that looks wrong?